197 related articles for article (PubMed ID: 27759996)
1. Association between sarcopenic obesity and cardiovascular risk: where are we?
Gusmao-Sena MH; Curvello-Silva K; Barreto-Medeiros JM; Da-Cunha-Daltro CH
Nutr Hosp; 2016 Sep; 33(5):592. PubMed ID: 27759996
[TBL] [Abstract][Full Text] [Related]
2. The implications of sarcopenia and sarcopenic obesity on cardiometabolic disease.
Kim TN; Choi KM
J Cell Biochem; 2015 Jul; 116(7):1171-8. PubMed ID: 25545054
[TBL] [Abstract][Full Text] [Related]
3. Body composition and its association with cardiometabolic risk factors in the elderly: a focus on sarcopenic obesity.
Chung JY; Kang HT; Lee DC; Lee HR; Lee YJ
Arch Gerontol Geriatr; 2013; 56(1):270-8. PubMed ID: 23079031
[TBL] [Abstract][Full Text] [Related]
4. Relationship between sarcopenic obesity and cardiovascular disease risk as estimated by the Framingham risk score.
Kim JH; Cho JJ; Park YS
J Korean Med Sci; 2015 Mar; 30(3):264-71. PubMed ID: 25729248
[TBL] [Abstract][Full Text] [Related]
5. Sarcopenic obesity as a determinant of cardiovascular disease risk in older people: a systematic review.
Evans K; Abdelhafiz D; Abdelhafiz AH
Postgrad Med; 2021 Nov; 133(8):831-842. PubMed ID: 34126036
[TBL] [Abstract][Full Text] [Related]
6. Oxidative stress is increased in sarcopenia and associated with cardiovascular disease risk in sarcopenic obesity.
Bellanti F; Romano AD; Lo Buglio A; Castriotta V; Guglielmi G; Greco A; Serviddio G; Vendemiale G
Maturitas; 2018 Mar; 109():6-12. PubMed ID: 29452783
[TBL] [Abstract][Full Text] [Related]
7. Sarcopenic Obesity and Cardiometabolic Health and Mortality in Older Adults: a Growing Health Concern in an Ageing Population.
Wannamethee SG; Atkins JL
Curr Diab Rep; 2023 Nov; 23(11):307-314. PubMed ID: 37566368
[TBL] [Abstract][Full Text] [Related]
8. Sarcopenic obesity and risk of cardiovascular disease and mortality: a population-based cohort study of older men.
Atkins JL; Whincup PH; Morris RW; Lennon LT; Papacosta O; Wannamethee SG
J Am Geriatr Soc; 2014 Feb; 62(2):253-60. PubMed ID: 24428349
[TBL] [Abstract][Full Text] [Related]
9. Associations between sarcopenic obesity and risk of cardiovascular disease: A population-based cohort study among middle-aged and older adults using the CHARLS.
Jiang M; Ren X; Han L; Zheng X
Clin Nutr; 2024 Mar; 43(3):796-802. PubMed ID: 38350287
[TBL] [Abstract][Full Text] [Related]
10. Sarcopenic obesity: epidemiology, pathophysiology, cardiovascular disease, mortality, and management.
Wei S; Nguyen TT; Zhang Y; Ryu D; Gariani K
Front Endocrinol (Lausanne); 2023; 14():1185221. PubMed ID: 37455897
[TBL] [Abstract][Full Text] [Related]
11. The Role of Sarcopenic Obesity in Cancer and Cardiovascular Disease: A Synthesis of the Evidence on Pathophysiological Aspects and Clinical Implications.
Silveira EA; da Silva Filho RR; Spexoto MCB; Haghighatdoost F; Sarrafzadegan N; de Oliveira C
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33919368
[TBL] [Abstract][Full Text] [Related]
12. Sarcopenic obesity in ageing: cardiovascular outcomes and mortality.
Atkins JL; Wannamathee SG
Br J Nutr; 2020 Nov; 124(10):1102-1113. PubMed ID: 32616084
[TBL] [Abstract][Full Text] [Related]
13. Sarcopenic obesity: A Critical appraisal of the current evidence.
Prado CM; Wells JC; Smith SR; Stephan BC; Siervo M
Clin Nutr; 2012 Oct; 31(5):583-601. PubMed ID: 22809635
[TBL] [Abstract][Full Text] [Related]
14. Associations of Sarcopenia and Sarcopenic Obesity With Metabolic Syndrome Considering Both Muscle Mass and Muscle Strength.
Lee J; Hong YP; Shin HJ; Lee W
J Prev Med Public Health; 2016 Jan; 49(1):35-44. PubMed ID: 26841883
[TBL] [Abstract][Full Text] [Related]
15. Sarcopenia and obesity.
Waters DL; Baumgartner RN
Clin Geriatr Med; 2011 Aug; 27(3):401-21. PubMed ID: 21824555
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of sarcopenia and sarcopenic obesity in the Korean population based on the Fourth Korean National Health and Nutritional Examination Surveys.
Kim YS; Lee Y; Chung YS; Lee DJ; Joo NS; Hong D; Song Ge; Kim HJ; Choi YJ; Kim KM
J Gerontol A Biol Sci Med Sci; 2012 Oct; 67(10):1107-13. PubMed ID: 22431554
[TBL] [Abstract][Full Text] [Related]
17. Sarcopenic obesity and 10-year cardiovascular disease risk scores in cancer survivors and non-cancer participants using a nationwide survey.
Lee K
Eur J Cancer Care (Engl); 2021 Mar; 30(2):e13365. PubMed ID: 33174666
[TBL] [Abstract][Full Text] [Related]
18. Sarcopenia and sarcopenic obesity.
Choi KM
Korean J Intern Med; 2016 Nov; 31(6):1054-1060. PubMed ID: 27809450
[TBL] [Abstract][Full Text] [Related]
19. Gamma-glutamyl transferase is associated with sarcopenia and sarcopenic obesity in community-dwelling older adults: results from the Fifth Korea National Health and Nutrition Examination Survey, 2010-2011.
Hong N; Lee EY; Kim CO
Endocr J; 2015; 62(7):585-92. PubMed ID: 25913781
[TBL] [Abstract][Full Text] [Related]
20. Effect of sarcopenia on cardiovascular disease risk factors in obese postmenopausal women.
Aubertin-Leheudre M; Lord C; Goulet ED; Khalil A; Dionne IJ
Obesity (Silver Spring); 2006 Dec; 14(12):2277-83. PubMed ID: 17189556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
